文献速递腹部CTMR

增强CT对Gd-EOB-DTPA MRI诊断为LR-3和LR-4观察对象的附加价值:CT与MR的廓清特征可否互换

Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable?
PubMed 文献 · Br J Radiol · 2022-01-05

回顾性纳入226个高危肝癌观察对象(162例患者),在钆塞酸增强MRI上诊断为LR-3或LR-4后,比较三种廓清标准诊断HCC的效能。加入CT廓清特征(标准2)后敏感度67.3%,高于仅用MRI门静脉期廓清(35.5%),特异度40.7% vs 38.4%无统计学差异。

要点

  • LI-RADS词典不允许跨模态互换影像特征,但补充动态CT廓清可提高LR-3/LR-4诊断HCC的敏感度。
  • 标准2(MRI门静脉期低信号和/或CT门静脉期/延迟期低密度)敏感度67.3%,特异度38.4%。
  • 标准3(MRI门静脉期和/或肝胆期低信号)敏感度最高92.5%,但特异度仅13%,显著低于标准1和2。

核心结论

  • 在钆塞酸增强MRI诊断为LR-3或LR-4的观察对象中,补充动态CT的廓清特征可在不降低特异度的情况下提高HCC诊断敏感度,尽管LI-RADS词典不允许跨模态互换影像特征。

研究设计与样本

  • 回顾性研究,纳入2015年3月至2018年3月间接受钆塞酸增强MRI和增强肝脏CT的高危HCC患者162例、共226个观察对象;两名放射科医师独立评估并以共识分配LI-RADS类别,排除LR-1、LR-2、LR-5和LR-M。

诊断标准与关键数值

  • 标准1:MRI门静脉期低信号,226个观察对象中98个有廓清,诊断HCC敏感度35.5%、特异度40.7%。标准2:MRI门静脉期低信号和/或动态CT门静脉期/延迟期低密度,226个观察对象中152个有廓清,敏感度67.3%、特异度38.4%。标准3:MRI门静脉期和/或肝胆期低信号,敏感度92.5%、特异度13%。标准2和3敏感度均显著高于标准1(p < 0.001);标准3特异度显著低于标准1和2(p < 0.001);标准1与标准2特异度无统计学差异(p = 0.427)。

临床应用与阅片要点

  • 作者指出,尽管LI-RADS词典不允许跨模态互换影像特征,在基于钆塞酸增强MRI的LR-3或LR-4类别中补充使用动态CT可能有助于主要影像特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To characterize the use of portal venous or delayed phase CT as an alternative to estimate washout for the non-invasive diagnosis of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI in combination with other features.

METHODS: This retrospective study included 226 observations (n = 162 patients) at high risk for HCC imaged with gadoxetic acid-enhanced MRI and enhanced liver CT between March 2015 and March 2018. Two radiologists independently evaluated two sets of images and assigned the final Liver Imaging Reporting and Data System (LI-RADS) categories by consensus using gadoxetic acid-enhanced MRI. LR-1, LR-2, LR-5, and LR-M were excluded from the study.The observations were divided using different criteria for washout: hypointensity on the portal venous phase (PVP) at MRI (criteria 1), hypointensity on PVP at MRI and/or hypoattenuation on the PVP/delayed phase at dynamic CT (criteria 2), and hypointensity on the PVP and/or hepatobiliary phase at MRI (criteria 3). The sensitivity, specificity, and accuracy for the diagnosis of HCC were analyzed for each criterion.

RESULTS: Using gadoxetic acid-enhanced, 226 lesions were diagnosed as LR-3 or LR-4 by LI-RADS. Among them, 98 and 152 had "washout" at criteria 1 and 2, respectively. For the diagnosis of HCC, criteria 2 and 3 showed significantly higher sensitivities (67.3 and 92.5%, respectively) compared with criteria 1 (35.5%) (p < 0.001). The specificity of criteria 3 (13%) was significantly lower than those of criteria 1 and 2 (40.7% and 38.4%, respectively, p < 0.001). The specificities between criteria 1 and 2 were not statistically different (p = 0.427).

CONCLUSION: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, the sensitivity of HCC diagnosis could be improved without any decrease in specificity by adding CT image washout features.

ADVANCES IN KNOWLEDGE: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, complementary use of dynamic CT in LR-3 or LR-4 categories on the basis of gadoxetic acid-enhanced MRI may contribute to major imaging feature.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lim, Kwon, Cho, et al. Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable? Br J Radiol. 2022. PMID: 34928175. doi:10.1259/bjr.20210738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。